| Ticker Details |
|
Twist Bioscience Corporation
|
| IPO Date: |
October 29, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$9.13B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.87 | 3.68%
|
| Avg Daily Range (30 D): |
$5.12 | 4.93%
|
| Avg Daily Range (90 D): |
$3.48 | 4.16%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.77M |
| Avg Daily Volume (30 D): |
1.31M |
| Avg Daily Volume (90 D): |
1.42M |
| Trade Size |
| Avg Trade Size (Sh.): |
55 |
| Avg Trade Size (Sh.) (30 D): |
54 |
| Avg Trade Size (Sh.) (90 D): |
56 |
| Institutional Trades |
| Total Institutional Trades: |
4,201 |
| Avg Institutional Trade: |
$3.58M |
| Avg Institutional Trade (30 D): |
$5.67M |
| Avg Institutional Trade (90 D): |
$4.93M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.13M |
| Avg Closing Trade (30 D): |
$21.11M |
| Avg Closing Trade (90 D): |
$19.45M |
| Avg Closing Volume: |
133K |
|
|
| Financials |
| |
TTM |
Q3 2026 |
Q2 2026 |
|
Basic EPS
|
$-2.22
|
$-.56
|
$-.71
|
|
Diluted EPS
|
$-2.22
|
$-.56
|
$-.71
|
|
Revenue
|
$431.8M
|
$118.38M
|
$110.72M
|
|
Gross Profit
|
$224.39M
|
$62.45M
|
$57.12M
|
|
Net Income / Loss
|
$-136.72M
|
$-35.05M
|
$-44.02M
|
|
Operating Income / Loss
|
$-144.98M
|
$-36.28M
|
$-45.86M
|
|
Cost of Revenue
|
$207.41M
|
$55.92M
|
$53.59M
|
|
Net Cash Flow
|
$-84.34M
|
$-5.29M
|
$-26.13M
|
|
PE Ratio
|
|
|
|
|
|
|